Cargando…
Harnessing MerTK agonism for targeted therapeutics
Phagocytosis plays important roles both in homeostasis and under pathological conditions. Fcγ receptor-mediated phagocytosis has been exploited as an integral mechanism for antibody-based therapies. Unlike Fcγ receptor-mediated phagocytosis, MerTK-mediated phagocytic clearance is immunologically sil...
Autores principales: | Kedage, Vivekananda, Ellerman, Diego, Chen, Yongmei, Liang, Wei-Ching, Borneo, Joven, Wu, Yan, Yan, Minhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927767/ https://www.ncbi.nlm.nih.gov/pubmed/31852344 http://dx.doi.org/10.1080/19420862.2019.1685832 |
Ejemplares similares
-
MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines
por: Kim, Jung Eun, et al.
Publicado: (2017) -
The Synthesis and Initial Evaluation of MerTK Targeted PET Agents
por: Wang, Li, et al.
Publicado: (2022) -
MerTK is a novel therapeutic target in gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2015) -
MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme
por: Knubel, Kristina H., et al.
Publicado: (2014) -
MerTK, a risk factor for NASH fibrosis
por: Wang, Xiaobo, et al.
Publicado: (2020)